Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V.
Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →
| Gewinn- und Verlustrechnung | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gesamtumsatz | €17.7B | €17.8B | €18.0B | €18.2B | €17.8B | €17.2B | €17.3B | €17.1B | €18.1B | €17.8B | €24.5B | €24.2B | €21.4B | €23.3B | €24.8B | €22.6B | €25.4B | €23.2B | €26.4B | €26.8B | €27.0B |
| Bruttoergebnis | €8.1B | €8.1B | €7.8B | €7.4B | €7.2B | €7.2B | €7.9B | €7.9B | €8.6B | €8.2B | €10.6B | €9.9B | €8.2B | €9.7B | €9.4B | €8.6B | €9.5B | €8.1B | €8.5B | €9.2B | €8.3B |
| Bruttomarge % | 45.9% | 45.2% | 43.1% | 41.0% | 40.4% | 41.8% | 45.7% | 46.4% | 47.2% | 46.0% | 43.3% | 40.6% | 38.4% | 41.5% | 38.0% | 38.3% | 37.5% | 34.8% | 32.1% | 34.2% | 30.8% |
| Betriebsergebnis (EBIT) | €1.7B | €1.4B | €529M | (€115M) | (€1.5B) | €553M | €1.3B | €1.4B | €1.7B | €1.5B | €1.9B | €992M | €486M | €2.0B | €1.0B | (€269M) | €2.1B | €614M | €54M | €1.9B | €1.2B |
| Operative Marge % | 9.7% | 8.0% | 2.9% | -0.6% | -8.6% | 3.2% | 7.3% | 8.0% | 9.5% | 8.5% | 7.7% | 4.1% | 2.3% | 8.5% | 4.2% | -1.2% | 8.1% | 2.6% | 0.2% | 6.9% | 4.4% |
| Jahresüberschuss | €1.1B | €895M | (€702M) | (€466M) | (€1.6B) | €3.3B | €1.2B | €1.2B | €1.1B | €1.7B | €1.4B | €645M | €415M | €1.2B | €226M | (€1.3B) | €1.4B | €410M | (€92M) | €4.2B | €5.4B |
| Nettomarge % | 6.3% | 5.0% | -3.9% | -2.6% | -9.0% | 19.4% | 6.9% | 6.8% | 6.0% | 9.3% | 5.9% | 2.7% | 1.9% | 5.0% | 0.9% | -5.7% | 5.7% | 1.8% | -0.4% | 15.6% | 20.0% |
| EBITDA | — | €2.6B | €1.8B | €1.0B | €115M | €2.0B | €2.8B | €2.6B | €2.8B | €2.6B | €2.4B | €1.8B | €1.8B | €3.1B | €1.9B | €1.0B | €3.6B | €2.3B | €656M | €2.7B | €2.0B |
| Ergebnis je Aktie (EPS) | €1.16 | €0.93 | €-0.75 | €-0.49 | €-1.69 | €3.49 | €1.24 | €1.20 | €1.09 | €1.64 | €1.46 | €0.66 | €0.42 | €1.19 | €0.23 | €-1.27 | €1.43 | €0.41 | €-0.09 | €3.57 | €4.27 |
| Ausstehende Aktien (Mio.) | — | 963M | 933M | 949M | 952M | 950M | 958M | 973M | 997M | 1,007M | 990M | 984M | 983M | 983M | 988M | 1,020M | 1,010M | 990M | 1,062M | 1,170M | 1,261M |
Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.
Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für PHG. /companies/us/PHG
Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.
About TickerBase · Data methodology & sources · Privacy · Terms